资讯
15 小时on MSN
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
16 小时on MSN
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果